Quick Heal Technologies Ltd

Q1 FY24 Earnings Call Analysis

IT - Software

Full Stock Analysis
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 2orderbook: No information
💰

fundraise

Any current/future new fundraising through debt or equity?

- No specific details on new fundraising through debt or equity were disclosed. - Vishal Salvi mentioned they have an in-principle approval for new investments and are now entering the execution phase. - The company does not disclose the actual amounts related to these investments publicly. - The company is zero debt currently, with a strong balance sheet and cash equivalents of Rs.226 crores as of FY24. - There is a focus on using internal resources and Board-approved plans for funding product portfolio strengthening and growth initiatives. - No mention was made of plans for raising fresh capital through external debt or equity in the near term.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- The company has received in-principle approval from the Board for new investments aimed at strengthening their product portfolio and expanding market reach, particularly in Horizon 2 and 3 solutions like EDR, XDR, Zero Trust, data privacy, and Gen AI-powered offerings. - These investments will be executed over the next few years, targeting an increase in the serviceable addressable market from Rs. 1800 crores to Rs. 4000 crores by FY27. - No specific amounts or detailed capex figures have been disclosed publicly. - The company plans to continue investing heavily in R&D and product development to maintain a strong Make in India cyber security portfolio and address evolving threats. - They aim to build new service capabilities (including managed detection and response) alongside product offerings over the next 3-5 years. - Inorganic opportunities such as acquisitions in cloud security or DLP engines are also being considered as strategic investments.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- The company aims to increase its addressable market from Rs. 1,800 crores to Rs. 4,000 crores over the next three years (FY25-FY27) through organic growth, new products, and market expansion into mid and large enterprises. - Enterprise segment revenue has grown from 20% to 37% and is expected to continue increasing, eventually becoming larger than the consumer business. - Enterprise cybersecurity industry is growing at 11-12% CAGR; the company expects to grow its enterprise segment faster than the industry average. - Consumer business faces headwinds but aims to maintain or marginally grow its market share through continued efforts. - Investments in Horizon 2 and 3 solutions (EDR, XDR, Zero Trust, Data Privacy, Gen AI adoption) supported by board-approved funding. - Strategic partnerships (e.g., M.Tech national distributor) and regulatory drivers (like DPDP Act) will support broader market penetration. - EBITDA expected to grow gradually as revenue growth outpaces expense growth.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- FY24 EBITDA margin improved significantly to 6% from less than 1% the previous year, with EBITDA standing at Rs.18 crores. - Expect gradual increase in EBITDA margin driven by revenue growth outpacing expense growth. - Operating expenses projected to rise with increased investment, especially in R&D and new product development. - Confident in higher revenue growth than industry (enterprise segment industry growth ~11-12% CAGR). - Focus on expanding addressable market from Rs.1800 crore to Rs.4000 crore by FY27 through new products, market segmentation, and regulatory drivers. - Consumer business relatively mature with higher margin; enterprise business still growing, focused on volume and market share at initial lower margins. - No explicit quarterly/annual EPS guidance provided, but margin expansion and revenue growth suggest improving profitability over next 3 years. - Board-approved investments expected to strengthen product portfolio, supporting sustained earnings growth.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- Government deals faced some deferrals due to the general elections and model code of conduct. - These deferred government deals are expected to be resurrected and concluded in favor of the company post-election. - Sales cycles for government contracts typically range between 6 to 9 months. - The company is confident about winning these government deals once election-related restrictions are lifted. - Enterprise segment traction is improving, with over 200 enterprise clients onboarded in FY24 for new products. - The company continues to consolidate and grow its presence in the SMB market, leveraging a strong partner network. - No explicit numeric order book value or pending order size was disclosed in the call.